133 related articles for article (PubMed ID: 1971777)
1. A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.
O'Connell JE; Dominiczak AF; Isles CG; McLellan AR; Davidson G; Gray CE; Connell JM
Clin Endocrinol (Oxf); 1990 Apr; 32(4):417-21. PubMed ID: 1971777
[TBL] [Abstract][Full Text] [Related]
2. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
3. Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
Graham SM; Genel M; Touloukian RJ; Barwick KW; Gertner JM; Torony C
J Pediatr Surg; 1987 Jun; 22(6):501-3. PubMed ID: 2886576
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinoma.
Schifter S
Eur J Cancer; 1992; 28(2-3):341-5. PubMed ID: 1350454
[TBL] [Abstract][Full Text] [Related]
5. Thyrotrophin releasing hormone induced calcitonin secretion in patients with medullary carcinoma of the thyroid.
Nakamura H; Someda H; Mori T; Imura H
Clin Endocrinol (Oxf); 1987 Jul; 27(1):69-74. PubMed ID: 3115636
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screening.
Schifter S
Clin Endocrinol (Oxf); 1989 Mar; 30(3):263-70. PubMed ID: 2574082
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A as tumor marker in medullary thyroid carcinoma.
Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type II: the role of gastrointestinal humoral factors in calcitonin release following alcohol and pentagastrin stimulation.
Fletcher DR; Gamvros O; Man WK; Ahmed Y; Trayner I; Adrian T
Aust N Z J Surg; 1984 Jun; 54(3):271-5. PubMed ID: 6147130
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
10. The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma.
Wells SA; Haagensen DE; Linehan WM; Farrell RE; Dilley WG
Cancer; 1978 Sep; 42(3 Suppl):1498-503. PubMed ID: 709521
[TBL] [Abstract][Full Text] [Related]
11. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Pina G; Dubois S; Murat A; Berger N; Niccoli P; Peix JL; Cohen R; Guillausseau C; Charrie A; Chabre O; Cornu C; Borson-Chazot F; Rohmer V;
Clin Endocrinol (Oxf); 2013 Mar; 78(3):358-64. PubMed ID: 22913268
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.
Lorenz K; Elwerr M; Machens A; Abuazab M; Holzhausen HJ; Dralle H
Langenbecks Arch Surg; 2013 Mar; 398(3):403-9. PubMed ID: 23408061
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
14. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.
Wells SA; Baylin SB; Linehan WM; Farrell RE; Cox EB; Cooper CW
Ann Surg; 1978 Aug; 188(2):139-41. PubMed ID: 686877
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging.
Wells SA; Baylin SB; Gann DS; Farrell RE; Dilley WG; Preissig SH; Linehan WM; Cooper CW
Ann Surg; 1978 Sep; 188(3):377-83. PubMed ID: 686900
[TBL] [Abstract][Full Text] [Related]
16. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families.
Wion-Barbot N; Schuffenecker I; Niccoli P; Conte-Devolx B; Lecomte P; Houdent C; Bigorgne JC; Modigliani E
Ann Endocrinol (Paris); 1997; 58(4):302-8. PubMed ID: 9436479
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
18. Urine calcitonin as a test for medullary thyroid cancer: a new screening procedure.
Silva OL; Snider RH; Moore CF; Becker KL
Ann Surg; 1979 Mar; 189(3):269-74. PubMed ID: 426557
[TBL] [Abstract][Full Text] [Related]
19. Experience with a provocative test of calcitonin release as a prospective screening for preclinical medullary thyroid carcinoma in MEN type 2A family members.
van Lathem JJ; Vermaak WJ; Kuyl JM; Mollentze W; Jansen S; Wolmarans L; Pelser H; Barry R; Kruger AJ; Wolfaardt M
J Clin Lab Anal; 1992; 6(6):384-90. PubMed ID: 1359042
[TBL] [Abstract][Full Text] [Related]
20. Pentagastrin promotes prolactin release in patients with medullary carcinoma of the thyroid.
Malarkey WB; Reynolds JC; O'Dorisio TM; Sizemore GW
Metabolism; 1984 May; 33(5):439-42. PubMed ID: 6144034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]